- Home
- TLSI vs SGC Comparison
TLSI vs SGC Comparison
Compare TLSI & SGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- SGC
- Stock Information
- Founded
- TLSI 2010
- SGC 1920
- Country
- TLSI United States
- SGC United States
- Employees
- TLSI N/A
- SGC N/A
- Industry
- TLSI Medical Specialities
- SGC Apparel
- Sector
- TLSI Health Care
- SGC Consumer Discretionary
- Exchange
- TLSI Nasdaq
- SGC Nasdaq
- Market Cap
- TLSI 244.3M
- SGC 215.7M
- IPO Year
- TLSI N/A
- SGC N/A
- Fundamental
- Price
- TLSI $6.21
- SGC $9.33
- Analyst Decision
- TLSI Strong Buy
- SGC Strong Buy
- Analyst Count
- TLSI 3
- SGC 3
- Target Price
- TLSI $10.67
- SGC $17.33
- AVG Volume (30 Days)
- TLSI 114.0K
- SGC 58.9K
- Earning Date
- TLSI 11-13-2025
- SGC 11-03-2025
- Dividend Yield
- TLSI N/A
- SGC 6.29%
- EPS Growth
- TLSI N/A
- SGC N/A
- EPS
- TLSI N/A
- SGC 0.36
- Revenue
- TLSI $40,207,000.00
- SGC $565,017,000.00
- Revenue This Year
- TLSI $57.25
- SGC $1.63
- Revenue Next Year
- TLSI $54.05
- SGC $3.28
- P/E Ratio
- TLSI N/A
- SGC $24.65
- Revenue Growth
- TLSI 49.52
- SGC N/A
- 52 Week Low
- TLSI $3.42
- SGC $8.30
- 52 Week High
- TLSI $6.36
- SGC $17.40
- Technical
- Relative Strength Index (RSI)
- TLSI 77.66
- SGC 50.73
- Support Level
- TLSI $3.79
- SGC $8.30
- Resistance Level
- TLSI $4.88
- SGC $9.75
- Average True Range (ATR)
- TLSI 0.47
- SGC 0.46
- MACD
- TLSI 0.17
- SGC 0.06
- Stochastic Oscillator
- TLSI 96.84
- SGC 78.62
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About SGC Superior Group of Companies Inc.
Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.